Xspray Pharma AB (publ) (STO:XSPRAY)

Sweden flag Sweden · Delayed Price · Currency is SEK
33.60
-1.05 (-3.03%)
At close: Feb 14, 2025
-22.22%
Market Cap 1.16B
Revenue (ttm) n/a
Net Income (ttm) -285.52M
Shares Out 37.14M
EPS (ttm) -8.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,511
Average Volume 18,590
Open 34.65
Previous Close 34.65
Day's Range 32.50 - 34.65
52-Week Range 28.65 - 90.61
Beta 0.77
RSI 42.09
Earnings Date Feb 12, 2025

About Xspray Pharma AB

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company’s product candidates include Dasynoc, a trailblazer, under approval phase for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib, under pivotal studies for the treatment of chronic myeloid leukemia; XS008, based on axitinib, under development for treatment of kidney cancer; and XS00Y under development phase. It has p... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 25
Stock Exchange Nasdaq Stockholm
Ticker Symbol XSPRAY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.